Literature DB >> 27283408

Current status of transcatheter valve therapy in Europe: results from an EAPCI survey.

Anna Sonia Petronio1, Piera Capranzano, Emanuele Barbato, Nicolo Piazza, Andreas Baumbach, Michael Haude, Stephan Windecker.   

Abstract

AIMS: Our aim was to identify current discrepancies among European countries, and provide a basis for a general agreement on decision making specifically related to TAVI procedures. The European Association of Percutaneous
Coronary Interventions (EAPCI) therefore assessed the current status of transcatheter valve therapy (TAVI) in Europe through a web-based survey. METHODS AND
RESULTS: Three hundred and one European centres responded to the survey (61.4% of the invited centres). Fewer than 200 TAVI procedures per site had been performed up to the date of response in 47% of centres, while over 500 procedures had been performed in 21% of centres. The Heart Team consisted mostly of interventional cardiologists and cardiac surgeons. In 79% of the centres, specific TAVI protocols are in place. Of note, 45% of centres perform TAVI in intermediate-risk patients, while only 10% do so in low-risk patients. Valve selection was based principally on patient-specific variables (74%), followed by operators' skills (55%), rates of valve-related complications (31%), and device cost (30%). Multislice computed tomography is the imaging modality most frequently performed prior to TAVI. Coronary revascularisation is usually performed before TAVI (86%), while no uniformity was observed in terms of antithrombotic therapy.
CONCLUSIONS: The EAPCI survey documents the current TAVI practice and penetration in Europe. Despite economic and regulatory difficulties, the procedure is increasingly performed and mostly according to specific protocols. The heterogeneity of the approach apparent in the survey suggests a call for an update in practice recommendations.

Entities:  

Mesh:

Year:  2016        PMID: 27283408     DOI: 10.4244/EIJY16M06_01

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  8 in total

Review 1.  Alternate Access for TAVI: Stay Clear of the Chest.

Authors:  Pavel Overtchouk; Thomas Modine
Journal:  Interv Cardiol       Date:  2018-09

2.  Transcatheter versus surgical aortic valve replacement in low and intermediate risk patients with severe aortic stenosis: systematic review and meta-analysis of randomized controlled trials and propensity score matching observational studies.

Authors:  Jintao Fu; Mohammad Sharif Popal; Yulin Li; Guoqi Li; Yue Qi; Fang Fang; Joey S W Kwong; Bin You; Xu Meng; Jie Du
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

3.  Transcatheter aortic valve implantation using the ACURATE TA™ system: 1-year outcomes and comparison of 500 patients from the SAVI registries.

Authors:  Jochen Börgermann; David M Holzhey; Matthias Thielmann; Evaldas Girdauskas; Holger Schroefel; Steffen Hofmann; Hendrik Treede; Klaus Matschke; Michael Hilker; Justus T Strauch; Thierry Carrel; Thorsten Wahlers; Anno Diegeler; Jörg Kempfert; Thomas Walther
Journal:  Eur J Cardiothorac Surg       Date:  2017-05-01       Impact factor: 4.191

4.  The Polish Interventional Cardiology TAVI Survey (PICTS): adoption and practice of transcatheter aortic valve implantation in Poland.

Authors:  Radosław Parma; Maciej Dąbrowski; Andrzej Ochała; Adam Witkowski; Dariusz Dudek; Zbigniew Siudak; Jacek Legutko
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-03-10       Impact factor: 1.426

5.  Clinical outcomes following transapical TAVR with ACURATE neo in the CHANGE neo TA study.

Authors:  Andreas Holzamer; Mirko Doss; Rene Schramm; Anno Diegeler; Lenard Conradi; Justus Strauch; David Holzhey; Magdalena Erlebach; Holger Schröfel; Mani Arsalan; Dominic J Allocco; Michael Hilker
Journal:  Int J Cardiol Heart Vasc       Date:  2021-08-31

6.  Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and intermediate risk: systematic review and meta-analysis.

Authors:  Reed A Siemieniuk; Thomas Agoritsas; Veena Manja; Tahira Devji; Yaping Chang; Malgorzata M Bala; Lehana Thabane; Gordon H Guyatt
Journal:  BMJ       Date:  2016-09-28

7.  Predicting hospitalisation duration after transcatheter aortic valve implantation.

Authors:  Martijn S van Mourik; Leonie M E Geenen; Ronak Delewi; Esther M A Wiegerinck; Karel T Koch; Berto J Bouma; Jose P Henriques; Robbert J de Winter; Jan Baan; M Marije Vis
Journal:  Open Heart       Date:  2017-04-24

8.  WorldwIde SurvEy on Clinical and Anatomical Factors Driving the Choice of Transcatheter Aortic Valve pRostheses.

Authors:  Luigi Biasco; Enrico Cerrato; Gregorio Tersalvi; Giovanni Pedrazzini; Ben Wilkins; Francesco Faletra; Enrico Ferrari; Stefanos Demertzis; Gaetano Senatore; Angelo Di Leo; Ferdinando Varbella; Ole De Backer; Luis Nombela Franco
Journal:  Front Cardiovasc Med       Date:  2020-03-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.